Abstract: From a first group of records of a set of transactions, a set of common transactions is extracted. The first group is formed based on a criterion. A record corresponds to a transaction in the set of transactions. A first transaction in the set of common transactions is classified into a transaction type. From a first actor associated with the first transaction, a first role corresponding to the first transaction is determined. Using the transaction type, the first role, and the time period, a transaction template, the transaction template comprising an action item and a role corresponding to the action item are determined. Using the first transaction template, a transaction is instantiated, the instantiating generating an action request corresponding to the action item and assigning an actor to the role.

Abstract: The present application relates to a composition, especially a cosmetic and/or dermatological composition, for topical application, comprising the combination of an aqueous, aqueous-alcoholic or aqueous-glycolic truffle extract with neohesperidin dihydrochalcone (neohesperidin DHC). The present invention also relates to the cosmetic use of said composition, and in particular for the care, hygiene, protection and/or making up of the skin of the body or of the face, or for caring for the hair, preferably for caring for the skin of the body or of the face.

Abstract: Disclosed herein is a composition for topical application to skin, comprising, in a physiologically acceptable medium (i) at least one peptide comprising at least one amino acid sequence derived from the amino acid sequence of the protein SNAP 25, and (ii) at least one calcium-channel inhibitor. Further disclosed is the use of this combination in a composition suitable for topical application to the skin, as an agent for preventing or treating wrinkles and fine lines, such as expression wrinkles, as well as a cosmetic treatment process comprising applying to the skin the composition.

Abstract: Disclosed herein is a composition for topical application to skin, comprising, in a physiologically acceptable medium (i) at least one peptide comprising at least one amino acid sequence derived from the amino acid sequence of the protein SNAP 25, and (ii) at least one calcium-channel inhibitor. Further disclosed is the use of this combination in a composition suitable for topical application to the skin, as an agent for preventing or treating wrinkles and fine lines, such as expression wrinkles, as well as a cosmetic treatment process comprising applying to the skin the composition.

Abstract: 7-Oxo-DHEA derivatives, various of which are themselves novel compounds, are well suited for cosmetically/therapeutically treating adverse conditions/afflictions of a keratinous substrate/material, notably of human skin, hair, eyelashes and nails, to improve the appearance thereof, in particular to prevent or treat signs of aging of the skin and/or a dull complexion and/or skin or hair pigmentation disorders and/or dryness of the skin and/or hyperseborrhoea and/or hyperseborrhoea-related imperfections and/or sensitive skin and/or dandruff and/or natural hair loss and/or baldness.

Abstract: 7-Oxo-DHEA derivatives, various of which are themselves novel compounds, are well suited for cosmetically/therapeutically treating adverse conditions/afflictions of a keratinous substrate/material, notably of human skin, hair, eyelashes and nails, to improve the appearance thereof, in particular to prevent or treat signs of aging of the skin and/or a dull complexion and/or skin or hair pigmentation disorders and/or dryness of the skin and/or hyperseborrhoea and/or hyperseborrhoea-related imperfections and/or sensitive skin and/or dandruff and/or natural hair loss and/or baldness.

Abstract: Disclosed herein is a composition for topical application to skin, comprising, in a physiologically acceptable medium (i) at least one peptide comprising at least one amino acid sequence derived from the amino acid sequence of the protein SNAP 25, and (ii) at least one calcium-channel inhibitor. Further disclosed is the use of this combination in a composition suitable for topical application to the skin, as an agent for preventing or treating wrinkles and fine lines, such as expression wrinkles, as well as a cosmetic treatment process comprising applying to the skin the composition.

Abstract: The invention relates to the use of cinnamic acid, or of at least one of its derivatives, in a cosmetic composition as an agent for promoting the synthesis of the skin's total lipids. The invention also relates to a cosmetic composition comprising an effective amount of cinnamic acid or of at least one of its derivatives.

Abstract: The present invention relates to the cosmetic use of 3&bgr;-acetoxy-7-oxo-DHEA to improve the appearance of keratin materials, with the exception of the treatment of wrinkles and fine lines, dry skin and dermatitis. This use is intended in particular for preventing or treating the loss of firmness of the skin and/or a dull complexion and/or dilation of the pores and/or skin or hair pigmentation disorders and/or hyperseborrhea and/or hyperseborrhea-related imperfections and/or sensitive skin and/or dandruff and/or hair loss and/or baldness.

Abstract: A method for preventing or combating chapping, tautness and/or redness comprising topical application onto skin or mucous membranes of a composition comprising, in a physiologically acceptable medium, preferably from 0.00001 to 0.1% of a retinoid and/or a carotenoid, and preferably from 0.001 to 1% of acexamic acid or a salt thereof is provided.

Abstract: Comixtures of escin and dextran sulfate are effective for treating skin redness/edema and/or sensitive skin, particularly redness and/or edema around the eyes and most particularly bags and/or dark rings around the eyes.

Abstract: 7-Oxo-DHEA derivatives, various of which are themselves novel compounds, are well suited for cosmetically/therapeutically treating adverse conditions/afflictions of a keratinous substrate/material, notably of human skin, hair, eyelashes and nails, to improve the appearance thereof, in particular to prevent or treat signs of aging of the skin and/or a dull complexion and/or skin or hair pigmentation disorders and/or dryness of the skin and/or hyperseborrhoea and/or hyperseborrhoea-related imperfections and/or sensitive skin and/or dandruff and/or natural hair loss and/or baldness.

Abstract: The invention concerns the use of at least one auxin in a cosmetic composition as agent for stimulating the synthesis of skin lipids.

Abstract: The invention relates to the use of cinnamic acid, or of at least one of its derivatives, in a cosmetic composition as an agent for promoting the synthesis of the skin's total lipids.

Abstract: The invention relates to the use of cinnamic acid, or of at least one of its derivatives, in a cosmetic composition as a firming agent for the skin and/or mucous membranes.

Abstract: The invention relates to the use of cinnamic acid, or of at least one of its derivatives, in a cosmetic composition as a firming agent for the skin and/or mucous membranes. The invention also relates to a firming composition comprising cinnamic acid or at least one of its derivatives.

Abstract: The invention relates to the use of cinnamic acid, or of at least one of its derivatives, in a cosmetic composition as an agent for promoting the synthesis of the skin's total lipids. The invention also relates to a cosmetic composition comprising an effective amount of cinnamic acid or of at least one of its derivatives.

Abstract: The subject-matter of the invention is a cosmetic composition comprising, in a cosmetically acceptable medium, at least phloroglucinol or one of its derivatives. Another subject-matter of the invention is the use of phloroglucinol or of its derivatives in a cosmetic composition intended to promote epidermal renewal.